DVAX - Spark Newswire

1 minute read

Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan

Today, 11:33 AM

Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ:DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan. Approximately 600,000 people…

DVAX

2 minute read

FDA
News

Medigen Vaccine Biologics, Dynavax Highlight Rollout Of Its COVID-19 Vaccine, MVC-COV1901; ~600K People Expected To Receive The Medigen Vaccine This Week

By Benzinga Newsdesk

Today, 11:33 AM

- Approximately 600,000 people are anticipated to receive the Medigen vaccine this week - MVC-COV1901 is a subunit vaccine comprised of recombinant SARS-CoV-2 S-2P antigen adjuvanted with CpG 1018(R)

DVAX

1 minute read

Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK

By Vandana Singh

Today, 11:33 AM

Valneva SE (NASDAQ:VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)…

DVAX

1 minute read

Earnings

Return on Capital Employed Overview: Dynavax Technologies

By Benzinga Insights

Today, 11:33 AM

Pulled from Benzinga Pro data Dynavax Technologies (NASDAQ:DVAX) posted Q2 earnings of $9.17 million, an increase from Q1 of 67.85%. Sales dropped to $52.77 million, a 36.68% decrease between quarters.

DVAX